Advertisement
Advertisement
AXSM
Axsome Therapeutics, Inc
244.31
USDSponsored
0.00
0.00%
Jul 03, 09:30 UTC -4
Closed
After-Market
241.50
-2.81
-1.15%
AXSM Earnings Reports
Positive Surprise Ratio
AXSM beat 21 of 42 last estimates.
50%
Next Report
Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$224.28M
/-$0.89
Implied change from Q1 26 (Revenue/ EPS)
+17.30%
/-29.37%
Implied change from Q2 25 (Revenue/ EPS)
+49.48%
/-8.25%
Axsome Therapeutics, Inc earnings per share and revenue
On May 04, 2026, AXSM reported earnings of -1.26 USD per share (EPS) for Q1 26, missing the estimate of -0.91 USD, resulting in a -37.87% surprise. Revenue reached 191.20 million, compared to an expected 194.03 million, with a -1.46% difference. The market reacted with a +8.31% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of -0.89 USD, with revenue projected to reach 224.28 million USD, implying an decrease of -29.37% EPS, and increase of 17.30% in Revenue from the last quarter.
FAQ
What were Axsome Therapeutics, Inc's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Axsome Therapeutics, Inc reported EPS of -$1.26, missing estimates by -37.87%, and revenue of $191.20M, -1.46% below expectations.
How did the market react to Axsome Therapeutics, Inc's Q1 2026 earnings?
The stock price moved up 8.31%, changed from $206.53 before the earnings release to $223.70 the day after.
When is Axsome Therapeutics, Inc expected to report next?
The next earning report is scheduled for Aug 03, 2026.
What are the forecasts for Axsome Therapeutics, Inc's next earnings report?
Based on 13
analysts, Axsome Therapeutics, Inc is expected to report EPS of -$0.89 and revenue of $224.28M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement